Clinical Trial Update: Hepcidin Behavior in Patients With Obesity and Bariatric Surgery

View source ↗

Summary

This clinical trial examining how the biomarker hepcidin behaves in people with obesity, including those who have undergone bariatric surgery, has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Hepcidin | Status: TERMINATED